Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 654 clinical trials
Multimodality Therapy for Palliative Resectable Hepatocellular Carcinoma With Intrahepatic Vessels Invasion

hepatocellular carcinoma with intrahepatic vessels invasion.

ethanol injection
local therapy
chemoembolization
percutaneous ethanol injection
hepatectomy
  • 2 views
  • 07 Nov, 2020
  • 1 location
Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria

The purpose of this study is to evaluate the influence of sirolimus on outcome after OLT for HCC exceeding Milan criteria.

vascular invasion
  • 1 views
  • 07 Nov, 2020
  • 1 location
Laparoscope Anatomical and Aon-anatomical Hepatectomy

The purpose of this study is to compare short-term and long-term efficacy of two surgical methods by laparoscopic hepatectomy, and provide the evidence for the choice of surgical method from the pathology and cytology.

metastasis
indocyanine green
radiofrequency ablation
hepatectomy
TACE
  • 4 views
  • 08 Nov, 2020
  • 1 location
Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma

receives about two to three cases of Hepatocellular carcinoma (HCC) each day in our Gastroenterology out patient department. Most of these patients present late when the disease is already

cirrhosis
chemoembolization
unresectable hepatocellular carcinoma
TACE
cancer
  • 30 views
  • 07 Nov, 2020
  • 1 location
A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver Cancer

Primary: To compare the efficacy of TACE and TAIE. Secondary: To compare the side effects of TACE and TAIE. The outcome measurements include survival benefit and tumour regression induced by the two therapies.

liver cancer
transcatheter arterial chemoembolisation
interferon
chemoembolization
TACE
  • 1 views
  • 07 Nov, 2020
  • 1 location
Genetic Polymorphisms of TNF- Promoter and HBV Genotype on Outcome of HBV-Related Chronic Liver Disease

The prognosis of Hepatitis B virus (HBV)infection varies from minimal progressive liver disease to cirrhosis or hepatocellular carcinoma (HCC).Both viral and host genetic factors

cirrhosis
carcinoma
tumor necrosis factor
tumor necrosis factor-alpha
hepatocellular carcinoma
  • 0 views
  • 07 Nov, 2020
  • 1 location
Evaluation of Quality of Life and Survival With MS-20 in Patient With Advanced Hepatocellular Carcinoma (FDA IND 74572)

To evaluate Quality of Life (QoL) score of MS-20 versus placebo in advanced HCC patients using European Organization for Research and Treatment of Cancer (EORTC) QLQ C-30 questionnaire.

cirrhosis
hepatoma
arterial embolization
systemic chemotherapy
hepatitis
  • 1 views
  • 07 Nov, 2020
  • 1 location
Ablation Plus Tislelizumab Versus Ablation Alone for Intrahepatic Recurrent Early Stage HCC

This is a randomized, controlled, phase 2 study to assess the efficacy and safety of ablation followed by tislelizumab versus ablation alone in patients with early recurrent hepatocellular

  • 0 views
  • 27 Jan, 2021
  • 1 location
The Safety and Efficacy of Deferoxamine for Treating Unresectable Hepatocellular Carcinoma

To investigate the safety and efficacy of deferoxamine (DFO) combined with conventional transarterial chemoembolization (TACE) in patients with unresectable hepatocellular carcinoma (HCC

  • 0 views
  • 22 Jan, 2021
A Study of CD147-targeted CAR-T by Hepatic Artery Infusions for Very Advanced Hepatocellular Carcinoma

This is a single-center, single-arm, open label and dose escalation clinical study of anti-CD147 CART cells by hepatic artery infusions in patients with advanced hepatocellular carcinoma.

  • 0 views
  • 23 Jan, 2021
  • 1 location